1. Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma. Issue 12 (19th December 2016) Authors: Imura, Yoshinori; Nakai, Takaaki; Yamada, Shutaro; Outani, Hidetatsu; Takenaka, Satoshi; Hamada, Kenichiro; Araki, Nobuhito; Itoh, Kazuyuki; Yoshikawa, Hideki; Naka, Norifumi Journal: Cancer science Issue: Volume 107:Issue 12(2016) Page Start: 1867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Involvement of valgus hindfoot deformity in hallux valgus deformity in rheumatoid arthritis. Issue 5 (September 2014) Authors: Yamada, Shutaro; Hirao, Makoto; Tsuboi, Hideki; Akita, Shosuke; Matsushita, Masato; Ohshima, Shiro; Saeki, Yukihiko; Hashimoto, Jun Journal: Modern rheumatology Issue: Volume 24:Issue 5(2014) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TAS‐115 inhibits PDGFRα/AXL/FLT‐3 signaling and suppresses lung metastasis of osteosarcoma. Issue 5 (30th March 2020) Authors: Yasuda, Naohiro; Takenaka, Satoshi; Nakai, Sho; Nakai, Takaaki; Yamada, Shutaro; Imura, Yoshinori; Outani, Hidetatsu; Hamada, Kenichiro; Yoshikawa, Hideki; Naka, Norifumi Journal: FEBS open bio Issue: Volume 10:Issue 5(2020) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma. (26th July 2017) Authors: Nakai, Takaaki; Imura, Yoshinori; Tamiya, Hironari; Yamada, Shutaro; Nakai, Sho; Yasuda, Naohiro; Kaneko, Keiko; Outani, Hidetatsu; Takenaka, Satoshi; Hamada, Kenichiro; Myoui, Akira; Araki, Nobuhito; Ueda, Takafumi; Itoh, Kazuyuki; Yoshikawa, Hideki; Naka, Norifumi Journal: Cancer medicine Issue: Volume 6:Number 9(2017:Sep.) Page Start: 2121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Trabectedin is a promising antitumour agent for synovial sarcoma. (2nd September 2016) Authors: Yasui, Hirohiko; Imura, Yoshinori; Outani, Hidetatsu; Hamada, Ken-ichiro; Nakai, Takaaki; Yamada, Shutaro; Takenaka, Satoshi; Sasagawa, Satoru; Araki, Nobuhito; Itoh, Kazuyuki; Myoui, Akira; Yoshikawa, Hideki; Naka, Norifumi Journal: Journal of chemotherapy Issue: Volume 28:Number 5(2016:Oct.) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗